Quick Answer
iBio, Inc. reported Stockholders Equity of $14.88 million for fiscal year 2025.
iBio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $14.88M | -30.2% |
| 2024 | $21.32M | +38.6% |
| 2023 | $15.38M | -75.8% |
| 2022 | $63.48M | -41.5% |
| 2021 | $108.58M | +91.8% |
| 2020 | $56.62M | +1330.8% |
| 2020 | $3.96M | +60.7% |
| 2019 | $2.46M | -84.8% |
| 2018 | $16.17M | +284.9% |
| 2018 | $4.20M | -52.9% |
| 2017 | $8.91M | -10.3% |
| 2016 | $9.94M | -11.5% |
| 2015 | $11.23M | +84.1% |
| 2014 | $6.10M | +20.3% |
| 2013 | $5.07M | -17.8% |
| 2012 | $6.17M | +3047.4% |
| 2011 | $196.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $56.56M | +307.1% | +0.9% |
| September 30, 2025 | $56.04M | +215.6% | +276.6% |
| June 30, 2025 | $14.88M | -30.2% | +30.7% |
| March 31, 2025 | $11.38M | -54.2% | -18.1% |
| December 31, 2024 | $13.89M | +51.1% | -21.7% |
| September 30, 2024 | $17.75M | +34.4% | -16.7% |
| June 30, 2024 | $21.32M | +38.6% | -14.2% |
| March 31, 2024 | $24.86M | +43.0% | +170.3% |
- iBio, Inc. showed a decrease of -30.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, iBio, Inc.’s stockholders equity has grown by 7491.8% (from $196.0 thousand to $14.88 million).
- The most recent figure is from iBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 5, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: